Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Hardman Talks Video | Surface Transforms (SCE): Placing

14 May 2024 13:49

Hardman & Co Research Hardman Talks Video | Surface Transforms (SCE): Placing 14-May-2024 / 13:49 GMT/BST The issuer is solely responsible for the content of this announcement.


Hardman Talks Video | Surface Transforms (SCE)

Surface Transforms placing

On Thursday 9 May 2024, the management of Surface Transforms joined us on Hardman Talks to talk about the plans to raise money by a placing and the intended use of the proceeds. On the call were David Bundred, Chairman, Kevin Johnson, CEO, Isabelle Maddock, CFO, and Stephen Easton, who recently joined as Chief Operations Officer.

Following the formal presentation there was an extensive Q&A session covering a wide range of issues of interest to investors. In particular, this was the first opportunity for retail investors to hear about the work of the new COO in driving up efficiency. An explanation was given as to why the placing was necessary and how the proceeds will be deployed.

Watch the recording: https://youtu.be/n7ICmNGjGhg

Read more about the event here: https://hardmanandco.com/hardman-talks-surface-transforms-placing/

To be first in the know about Hardman & Co’s latest digital events, subscribe to the mailing list here.

The Hardman Talks series is designed to share the latest sector insights and company investment cases from our corporate clients and our expert team of analysts. Click here to subscribe to the Hardman Talks channel on YouTube.

Hardman & Co | 9 Bonhill Street | London | EC2A 4DJ | www.hardmanandco.com

Ā 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors’ understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies’ profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1902885 14-May-2024Ā 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
29th Feb 20129:30 amRNSDirector/PDMR Shareholding
21st Feb 201210:04 amRNSGrant of Share Options
31st Jan 20127:00 amRNSHalf Yearly Report
25th Jan 201211:15 amRNSNew Distribution Agreement
23rd Jan 20123:45 pmRNSIssue of Options
15th Nov 201110:35 amRNSDirector Shareholding
4th Nov 201110:37 amRNSHolding(s) in Company
21st Oct 201111:30 amRNSDirector/PDMR Shareholding
19th Oct 20117:00 amRNSHolding(s) in Company
17th Oct 20117:00 amRNSResult of AGM and Directorate Changes
8th Aug 20112:35 pmRNSDirector/PDMR Shareholding
5th Aug 20117:01 amRNSDirectorate Change
5th Aug 20117:00 amRNSFinal Results and Notice of Annual General Meeting
16th Jun 20117:00 amRNSPre Close Trading Statement
3rd Mar 20117:00 amRNSSurface Transforms signs Distribution Agreement
24th Feb 20117:00 amRNSHalf Yearly Financial Results
7th Feb 201112:40 pmRNSNotice of Half Yearly Report - replacement
7th Feb 201111:54 amRNSHalf Yearly Report
25th Nov 20102:00 pmRNSResult of EGM and of the Placing and Open Offer
3rd Nov 20107:00 amRNSShareholder Circular of Placing and Open Offer
5th Oct 20107:00 amRNSNew Development Agreement
29th Sep 201011:04 amRNSResult of AGM
16th Aug 20107:00 amRNSFinal Results & Notice of AGM
3rd Jun 20107:00 amRNSDRAFT PRE CLOSE TRADING STATEMENT
9th Mar 20107:00 amRNSDirector/PDMR Shareholding
2nd Mar 201010:00 amRNSGrant of share options
2nd Mar 20107:00 amRNSDirector/PDMR Shareholding
25th Feb 20103:06 pmRNSHolding(s) in Company
24th Feb 20107:00 amRNSHalf-Yearly Results
8th Dec 20097:00 amRNSPlacing
13th Oct 20097:00 amRNSCollaborative R&D project
30th Sep 200910:31 amRNSAppointment of Non Executive Director
29th Sep 20094:02 pmRNSResult of AGM
18th Aug 20097:00 amRNSAnnual Results
17th Aug 200911:59 amRNSHoldings in Company / TVR
12th Aug 20091:16 pmRNSResult of EGM
30th Jul 20097:00 amRNSNew Contract
20th Jul 20097:00 amRNSPlacing
10th Jun 20094:30 pmRNSPre-close Trading Statement - Replacement
10th Jun 200911:40 amRNSPre-close Trading Statement
28th May 200912:08 pmRNSChange of Adviser
26th May 20093:31 pmPRNHolding(s) in Company
9th Apr 20093:05 pmPRNHolding(s) in Company
30th Mar 20094:34 pmPRNHolding(s) in Company
17th Mar 20092:59 pmPRNHolding(s) in Company
26th Feb 20093:09 pmPRNHolding(s) in Company
11th Feb 20097:00 amPRNHalf-yearly Report
7th Jan 200912:56 pmPRNHolding(s) in Company
11th Dec 20087:00 amPRNNew Orders in the Defence Sector
8th Dec 20087:00 amPRNTrading Update and Board Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.